Beacon Pointe Advisors’s Steris STE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$265K Buy
1,255
+294
+31% +$63K ﹤0.01% 1671
2026
Q1
$212K Buy
+961
New +$235K ﹤0.01% 1703
2023
Q4
Sell
-3,419
Closed -$750K 1390
2023
Q3
$750K Buy
3,419
+219
+7% +$49.5K 0.01% 722
2023
Q2
$720K Buy
+3,200
New +$640K 0.01% 614
2022
Q3
Sell
-979
Closed -$200K 1053
2022
Q2
$200K Sell
979
-2,483
-72% -$560K ﹤0.01% 970
2022
Q1
$837K Buy
+3,462
New +$803K 0.01% 671

Other funds holding STE

Beacon Pointe Advisors's STE Position: Q2 2026 in Review

Beacon Pointe Advisors increased its Steris (STE) stake by 31% in Q2 2026, buying an estimated $63K and bringing the position to 1,255 shares worth $265K. The position accounts for ﹤0.01% of the portfolio, ranked #1671.

Beacon Pointe Advisors first reported a position in STE in Q1 2022 and has held it in 6 quarters since. The position peaked at $837K in Q1 2022. 830 funds tracked by Wall St. Rank hold STE as of Q2 2026.

  • Beacon Pointe Advisors held 1,255 shares of Steris worth $265K as of Q2 2026.
  • Beacon Pointe Advisors bought 294 Steris shares in Q2 2026, an estimated $63K.
  • Steris made up ﹤0.01% of Beacon Pointe Advisors's portfolio in Q2 2026, its #1671 holding.
  • Beacon Pointe Advisors first reported a position in Steris in Q1 2022 and has held it in 6 quarters since.
  • Beacon Pointe Advisors's Steris position peaked at $837K in Q1 2022.
  • 830 funds tracked by Wall St. Rank held Steris as of Q2 2026.

Based on Beacon Pointe Advisors's 13F filing for Q2 2026, filed 18 Aug 2026.